Dr. Ryan Carter Young, MD

Dr. Young practices at Austin Retina Associates in Austin, Texas.

Dr. Young's NPI, 1902127947, was assigned on June 14, 2010. Dr. Young graduated from Mayo Clinic Alix School of Medicine - Rochester in 2010. Dr. Young holds Texas license Q6384.

Dr. Young's primary practice is Austin Retina Associates, at 801 W 38th St, Austin, TX 78705 in Travis County. The practice phone is (512) 451-0103.

Dr. Young's primary practice is Austin Retina Associates in Austin, Texas. Dmand AI also links Dr. Young to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Young is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Young's licenses on file in 3 states: Texas, Florida and Iowa.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Young treats.

CMS data shows 17,748 Medicare services from Dr. Young across 18 procedure codes in 2024, for 996 Medicare patients. Medicare paid $2,575,277 for them.

CMS counts 996 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 405 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 72, with 52% women.

In 2024, Dr. Young wrote 394 Medicare Part D claims for 185 patients. 67% of them were for generic drugs. CMS names the drug for 319 of them, across 9 drugs with 11 or more claims each, at $5,894 in total drug cost. In 2023, CMS named 426 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Young for performance year 2024, reported individually. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Young, published from 2013 to 2021. 2018 was the busiest year, with 3. The most frequent topics are Retinopathy of Prematurity, Fluorescein Angiography and Fundus Oculi. Dr. Young has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Young's most frequent co-authors are Clio Armitage Harper, MD, Hassan Aziz, MD and Harry W. Flynn, MD.

CMS Open Payments shows 122 general payments to Dr. Young from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Baxter Healthcare paid the most, $101,595.

Dr. Young graduated from Mayo Clinic Alix School of Medicine - Rochester in 2010.

Dr. Young is in network with 25 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 16. Check the plan with the practice before a visit.